Current state of resistance to antibiotics of last-resort in South Africa: A review from a public health perspective

Frontiers in Public Health

Volumn 4, Issue SEP, 2016, Pages

  Sekyere, John Osei ^a,b  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Antibiotic resistance; Carbapenem; Carbapenemase; Colistin; Mcr 1; South Africa; Tigecycline

Indexed keywords

EID: 85015289166     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/FPUBH.2016.00209     Document Type: Review

References (61)

1. WHO. Antimicrobial Resistance: Global Report on Surveillance. France: World Health Organization (2014).
2. WHO. Tackling Antibiotic Resistance from a Food Safety Perspective in Europe, Word Health Organization. Denmark: WHO-Europe (2011).
3. European Union. Antibiot. Aware. Day. (2015). Available from: http://ecdc.europa.eu/en/EAAD/Pages/Home.aspx
4. White House. Pledge to Love, Prot. Cherish Antibiot. (2015). Available from: https://www.whitehouse.gov/blog/2015/06/05/pledge-love-protect-and-cherish-antibiotics
5. Bester LA, Essack SY. Antibiotic resistance via the food chain: fact or fiction? S Afr J Sci (2010) 106:1-5. doi:10.4102/sajs.v106i9/10.281
6. Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agersø Y, et al. Detection of MCR-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill (2015) 20:30085. doi:10.2807/1560-7917.ES.2015.20.49.30085
7. Liu Y-Y, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis (2016) 16:161-8. doi:10.1016/S1473-3099(15)00424-7
8. Hueston W, Appert J, Denny T, King L, Umber J, Valeri L. Assessing global adoption of one health approaches. Ecohealth (2013) 10:228-33. doi:10.1007/s10393-013-0851-5
9. Rowe W, Verner-Jeffreys DW, Baker-Austin C, Ryan JJ, Maskell DJ, Pearce GP. Comparative metagenomics reveals a diverse range of antimicrobial resistance genes in effluents entering a river catchment. Water Sci Technol (2016) 73(7):1541-9. doi:10.2166/wst.2015.634
10. Rashid M, Rakib MM, Hasan B. Antimicrobial-resistant and ESBL-producing Escherichia coli in different ecological niches in Bangladesh. Infect Ecol Epidemiol (2015) 5:26712. doi:10.3402/iee.v5.26712
11. Toleman MA, Bugert JJ, Nizam SA. Extensively drug-resistant New Delhi metallo-β-lactamase-encoding bacteria in the environment, Dhaka, Bangladesh, 2012. Emerg Infect Dis (2015) 21:1027-30. doi:10.3201/eid2106.141578
12. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis (2011) 11:355-62. doi:10.1016/S1473-3099(11)70059-7
13. Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis (2013) 13:1057-98. doi:10.1016/S1473-3099(13)70318-9
14. Osei Sekyere J, Govinden U, Bester LA, Essack SY. Colistin and tigecycline resistance in carbapenemase-producing Gram negative bacteria: emerging resistance mechanisms and detection methods. J Appl Microbiol (2016) 121(3):601-17. doi:10.1111/jam.13169
15. Osei Sekyere J, Pedersen T, Sivertsen A, Govinden U, Essack SY, Moodley K, et al. Molecular epidemiology of carbapenem, colistin and tigecycline resistant Enterobacteriaceae in Durban, South Africa. ECCMID Poster Presentation, Amsterdam (2016). doi:10.13140/RG.2.1.1049.0003
16. Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect (2014) 20:821-30. doi:10.1111/1469-0691.12719
17. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev (2007) 20:440-58. doi:10.1128/CMR.00001-07
18. Sekyere JO, Govinden U, Essack S. The molecular epidemiology and genetic environment of carbapenemases detected in Africa. Microb Drug Resist (2015) 22:59-68. doi:10.1089/mdr.2015.0053
19. Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. Annu Rev Microbiol (2011) 65:455-78. doi:10.1146/annurev-micro-090110-102911
20. Schwarz S, Johnson AP. Transferable resistance to colistin: a new but old threat: table 1. J Antimicrob Chemother (2016) 71(8):2066-70. doi:10.1093/jac/dkw274
21. Poirel L, Weldhagen GF, Naas T, De Champs C, Dove MG, Nordmann P. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother (2001) 45:2598-603. doi:10.1128/AAC.45.9.2598-2603.2001
22. Obi CL, Ramalivhana J, Samie A, Igumbor EO. Prevalence, pathogenesis, antibiotic susceptibility profiles, and in-vitro activity of selected medicinal plants against Aeromonas isolates from stool samples of patients in the Venda region of South Africa. J Health Popul Nutr (2007) 25(4):428-35.
23. Elliott E, Brink AJ, van Greune J, Els Z, Woodford N, Turton J, et al. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase. Clin Infect Dis (2006) 42:e95-8. doi:10.1086/503264
24. Segal H, Elisha BG. Resistance to β-lactams, and reduced susceptibility to carbapenems, in clinical isolates of Klebsiella pneumoniae due to interplay between CTX-M-15 and altered outer membrane permeability. South Afr J Epidemiol Infect (2006) 21(2):41-4.
25. Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii1. Emerg Infect Dis (2010) 16:35. doi:10.3201/eid1601.090852
26. Bisi-Johnson M, Obi C. Detection of carbapenem resistance in Salmonella species from a tertiary hospital in Eastern Cape, South Africa. Br Microbiol Res J (2015) 10:1-6. doi:10.9734/BMRJ/2015/18586
27. Zander E, Higgins PG, Fernández-González A, Seifert H. Detection of intrinsic blaOXA-51-like by multiplex PCR on its own is not reliable for the identification of Acinetobacter baumannii. Int J Med Microbiol (2013) 303:88-9. doi:10.1016/j.ijmm.2012.12.007
28. Kock MM, Bellomo AN, Storm N, Ehlers MM. Prevalence of carbapenem resistance genes in Acinetobacter baumanii isolated from clinical specimens obtained from an academic hospital in South Africa. South Afr J Epidemiol Infect (2013) 23:28-32.
29. Ahmed NH, Baba K, Clay C, Lekalakala R, Hoosen AA. In vitro activity of tigecycline against clinical isolates of carbapenem resistant Acinetobacter baumannii complex in Pretoria, South Africa. BMC Res Notes (2012) 5:215. doi:10.1186/1756-0500-5-215
30. Jacobson RK, Minenza N, Nicol M, Bamford C. VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa causing an outbreak in South Africa. J Antimicrob Chemother (2012) 67:1797-8. doi:10.1093/jac/dks100
31. Perovic O, Singh-Moodley A, Dusé A, Bamford C, Elliott G, Swe-Han K, et al. National sentinel site surveillance for antimicrobial resistance in Klebsiella pneumoniae isolates in South Africa, 2010-2012. S Afr Med J (2014) 104:563-8. doi:10.7196/samj.7617
32. Peirano G, Moolman J, Pitondo-Silva A, Pitout JDD. The characteristics of VIM-1-producing Klebsiella pneumoniae from South Africa. Scand J Infect Dis (2012) 44:74-8. doi:10.3109/00365548.2011.614276
33. Lowman W, Sriruttan C, Nana T, Bosman N, Duse A, Venturas J, et al. NDM-1 has arrived: first report of a carbapenem resistance mechanism in South Africa. S Afr Med J (2011) 101:873-5.
34. Brink AJ, Coetzee J, Clay C, Corcoran C, van Greune J, Deetlefs JD, et al. The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention. S Afr Med J (2012) 102:599-601. doi:10.7196/SAMJ.5789
35. Brink AJ, Coetzee J, Corcoran C, Clay CG, Hari-Makkan D, Jacobson RK, et al. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J Clin Microbiol (2013) 51:369-72. doi:10.1128/JCM.02234-12
36. de Jager P, Chirwa T, Naidoo S, Perovic O, Thomas J. Nosocomial outbreak of New Delhi metallo-β-lactamase-1-producing Gram-negative bacteria in South Africa: a case-control study. PLoS One (2015) 10:e0123337. doi:10.1371/journal.pone.0123337
37. Govind CN, Moodley K, Mahabeer P, Khan S. The emergence of carbapenem resistant Enterobacteriaceae in KwaZulu Natal, South Africa. 5th FIDSSA Conference 2013. Drakensberg, KwaZulu Natal, South Africa: South Afr J Epidemiol Infect (2013). 217 p.
38. Govind CN, Moodley K, Peer AK, Pillay N, Maske C, Wallis C, et al. NDM-1 imported from India-first reported case in South Africa. S Afr Med J (2013) 103:476-8. doi:10.7196/SAMJ.6593
39. Rubin JE, Peirano G, Peer AK, Govind CN, Pitout JDD. NDM-1-producing Enterobacteriaceae from South Africa: moving towards endemicity? Diagn Microbiol Infect Dis (2014) 79:378-80. doi:10.1016/j.diagmicrobio.2014.04.003
40. Jacobson RK, Manesen MR, Moodley C, Smith M, Williams S, Nicol M, et al. Molecular characterisation and epidemiological investigation of an outbreak of blaOXA-181 carbapenemase-producing isolates of Klebsiella pneumoniae in South Africa. S Afr Med J (2015) 105:1030-5. doi:10.7196/SAMJ.2015.v105i12.9926
41. Chibabhai V, Perovic O. Epidemiology of carbapenem resistant Enterobacteriaceae at Charlotte Maxeke Johannesburg Academic Hospital. Int J Infect Dis (2014) 21:410. doi:10.1016/j.ijid.2014.03.1265
42. Mhlongo N, Essack S, Govinden U. NDM-1, novel TEM-205, novel TEM-213 and other extended-spectrum β-lactamases co-expressed in isolates from cystic fibrosis patients from South Africa. S Afr J Infect Dis (2015) 30:103-7. doi:10.1080/23120053.2015.1074441
43. Govender K. Detection of Carbapenem-Resistant Enterobacteriaceae amongst Neonates in a Regional Hospital in KwaZulu-Natal: Screening for Carbapenemase Production and MIC Correlation. Durban: University of KwaZulu-Natal (2014). Available from: http://researchspace.ukzn.ac.za/handle/10413/12030
44. Zander E, Fernández-González A, Schleicher X, Dammhayn C, Kamolvit W, Seifert H, et al. Worldwide dissemination of acquired carbapenem-hydrolysing class D β-lactamases in Acinetobacter spp. other than Acinetobacter baumannii. Int J Antimicrob Agents (2014) 43:375-7. doi:10.1016/j.ijantimicag.2014.01.012
45. Mahabeer P, Singh R, Moodley P. NDM-1 producing Klebsiella pneumoniae in a neonate. 5th FIDSSA Conference. Drakensberg, KwaZulu Natal: Southern African Journal of Epidemiology and Infection (2013) 28(3):218.
46. Singh R, Mahabeer P, Mlisana K, Naidoo K, Moodley P. Isolation of New Delhi metallo-βeta-lactamase-1(NDM-1) producing Klebsiella pneumoniae in a neonate in KwaZulu-Natal, South Africa. J Pediatr Neonatal Care (2015) 2:1-2. doi:10.15406/jpnc.2015.02.00082
47. National Institute for Communicable Diseases. Update on carbapenemase-producing Enterobacteriaceae. NICD Commun Dis Commun. (2016). Available from: http://www.nicd.ac.za/?page=archives&id=134
48. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis (2014) 14(8):742-50. doi:10.1016/S1473-3099(14)70780-7
49. Coetzee J, Corcoran C, Prentice E, Moodley M, Mendelson M, Poirel L, et al. Emergence of plasmid-mediated colistin resistance (MCR-1) among Escherichia coli isolated from South African patients. S Afr Med J (2016) 106:449-50. doi:10.7196/SAMJ.2016.v106i5.10710
50. Poirel L, Kieffer N, Brink A, Coetze J, Jayol A, Nordmann P. Genetic features of MCR-1-producing colistin-resistant Escherichia coli isolates, South Africa. Antimicrob Agents Chemother (2016) 60(7):4394-7. doi:10.1128/AAC.00444-16
51. Doi Y, Paterson DL. Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med (2015) 36:74-84. doi:10.1055/s-0035-1544208
52. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis (2011) 17:1791-8. doi:10.3201/eid1710.110655
53. Brink AJ, Coetzee J, Clay CG, Sithole S, Richards GA, Poirel L, et al. Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J Clin Microbiol (2012) 50:525-7. doi:10.1128/JCM.05956-11
54. Coetzee J, Brink AJ. The emergence of carbapenem resistance in Enterobacteriaceae in South Africa. South Afr J Epidemiol Infect (2011) 26:239-40.
55. Crush J, Chikanda A, Maswikwa B. Patients without Borders: Medical Tourism and Medical Migration in Southern Africa. Cape Town and Toronto: Southern African Migration Programme (2012).
56. Stein C, Makarewicz O, Bohnert JA, Pfeifer Y, Kesselmeier M, Hagel S, et al. Three dimensional checkerboard synergy analysis of colistin, meropenem, tigecycline against multidrug-resistant clinical Klebsiella pneumonia isolates. PLoS One (2015) 10:e0126479. doi:10.1371/journal.pone.0126479
57. Tascini C, Tagliaferri E, Giani T, Leonildi A, Flammini S, Casini B, et al. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother (2013) 57:3990-3. doi:10.1128/AAC.00179-13
58. Giani T, Arena F, Vaggelli G, Conte V, Chiarelli A, Henrici De Angelis L, et al. Large nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant. J Clin Microbiol (2015) 53:3341-4. doi:10.1128/JCM.01017-15
59. Perovic O. FIDSSA Congress 2015 abstract submissions oral presentations. S Afr J Infect Dis (2015) 30:177-90.
60. Centers for Disease Control and Prevention (CDC). Risk of CRE Infections. CDC Vital Signs Rep. Atlanta, Georgia: Centers for Disease Control and Prevention (2013) 62(09):165-170.
61. Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother (2001) 48(Suppl 1):87-102. doi:10.1093/jac/48.suppl_1.87